» Articles » PMID: 38994964

Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration

Overview
Journal Cells
Publisher MDPI
Date 2024 Jul 12
PMID 38994964
Authors
Affiliations
Soon will be listed here.
Abstract

Aggregation of the microtubule-associated protein tau (MAPT) is the hallmark pathology in a spectrum of neurodegenerative disorders collectively called tauopathies. Physiologically, tau is an inherent neuronal protein that plays an important role in the assembly of microtubules and axonal transport. However, disease-associated mutations of this protein reduce its binding to the microtubule components and promote self-aggregation, leading to formation of tangles in neurons. Tau is also expressed in oligodendrocytes, where it has significant developmental roles in oligodendrocyte maturation and myelin synthesis. Oligodendrocyte-specific tau pathology, in the form of fibrils and coiled coils, is evident in major tauopathies including progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick's disease (PiD). Multiple animal models of tauopathy expressing mutant forms of MAPT recapitulate oligodendroglial tau inclusions with potential to cause degeneration/malfunction of oligodendrocytes and affecting the neuronal myelin sheath. Till now, mechanistic studies heavily concentrated on elucidating neuronal tau pathology. Therefore, more investigations are warranted to comprehensively address tau-induced pathologies in oligodendrocytes. The present review provides the current knowledge available in the literature about the intricate relations between tau and oligodendrocytes in health and diseases.

Citing Articles

Toward an animal model of Progressive Supranuclear Palsy.

Priyanka , Qamar S, Visanji N Front Neurosci. 2024; 18:1433465.

PMID: 39420986 PMC: 11484047. DOI: 10.3389/fnins.2024.1433465.

References
1.
Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K . Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci. 2005; 25(46):10637-47. PMC: 6725849. DOI: 10.1523/JNEUROSCI.3279-05.2005. View

2.
Oddo S, Caccamo A, Shepherd J, Murphy M, Golde T, Kayed R . Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003; 39(3):409-21. DOI: 10.1016/s0896-6273(03)00434-3. View

3.
Brion J, Couck A, Passareiro E, FLAMENT-DURAND J . Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. J Submicrosc Cytol. 1985; 17(1):89-96. View

4.
Poorkaj P, Bird T, Wijsman E, Nemens E, Garruto R, Anderson L . Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998; 43(6):815-25. DOI: 10.1002/ana.410430617. View

5.
Ludvigson A, Luebke J, Lewis J, Peters A . Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study. Brain Struct Funct. 2010; 216(1):31-42. PMC: 3748379. DOI: 10.1007/s00429-010-0295-4. View